Age-associated alterations in splenic iNOS regulation: influence of constitutively expressed IFN-gamma and correction following supplementation with PPARalpha activators or vitamin E

Cell Immunol. 1999 Aug 1;195(2):127-36. doi: 10.1006/cimm.1999.1525.

Abstract

Alterations in transcription factor activities in aged mice may lead to the production of many inflammatory molecules in the absence of exogenous stimulation. Splenocytes from 22-month-old female C57BL/6 mice are dysregulated in their capacity to control the inducible nitric oxide synthase gene as a result of elevations in the endogenous levels and activity of interferon (IFN)-gamma. Splenocytes from aged mice produced high levels of IFN-gamma in vitro and active STAT-1 was found in nuclear extracts from these splenocytes. Administration to aged mice of neutralizing antibodies against IFN-gamma imposed appropriate regulation over nitric oxide production by stimulated splenocytes. Reestablishment of normal redox balance following dietary supplementation of aged mice with activators of the peroxisome proliferator-activated receptor alpha or the antioxidant alpha-tocopherol (vitamin E) restored appropriate regulation over both the production of IFN-gamma and the secretion of nitric oxide.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aging / metabolism*
  • Animals
  • Antibodies / immunology
  • Cell Nucleus / metabolism
  • DNA-Binding Proteins / metabolism
  • Enzyme Induction / drug effects
  • Female
  • Interferon-gamma / biosynthesis
  • Interferon-gamma / immunology
  • Interferon-gamma / metabolism*
  • Interferon-gamma / pharmacology
  • Lipopolysaccharides / pharmacology
  • Macrophages / cytology
  • Macrophages / drug effects
  • Macrophages / enzymology
  • Macrophages / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Nitric Oxide / metabolism
  • Nitric Oxide / urine
  • Nitric Oxide Synthase / genetics
  • Nitric Oxide Synthase / metabolism*
  • Nitric Oxide Synthase Type II
  • Oxidation-Reduction
  • Pyrimidines / administration & dosage
  • Pyrimidines / pharmacology
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Receptors, Cytoplasmic and Nuclear / agonists*
  • Receptors, Cytoplasmic and Nuclear / physiology
  • STAT1 Transcription Factor
  • Spleen / cytology
  • Spleen / drug effects
  • Spleen / enzymology*
  • Spleen / metabolism
  • Trans-Activators / metabolism
  • Transcription Factors / agonists*
  • Transcription Factors / physiology
  • Vitamin E / administration & dosage
  • Vitamin E / pharmacology*

Substances

  • Antibodies
  • DNA-Binding Proteins
  • Lipopolysaccharides
  • Pyrimidines
  • RNA, Messenger
  • Receptors, Cytoplasmic and Nuclear
  • STAT1 Transcription Factor
  • Stat1 protein, mouse
  • Trans-Activators
  • Transcription Factors
  • Vitamin E
  • Nitric Oxide
  • Interferon-gamma
  • pirinixic acid
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse